With the introduction of Dihydroartemisinin-piperaquine (DHAP) and artesunate-pyronaridine (ASPY) on the list of anti-malarial drugs available in Rwanda, the number of treatments that can be ...

Charting, Price Performance, News & Related Contracts.

A discredited study that set off a flurry of interest in using an antimalarial drug to treat COVID-19 has now been formally withdrawn. A scientific journal on Tuesday retracted the March 2020 ...

Adnexus Biotechnologies Inc. is at the forefront of the battle against malaria by developing Trapicolast, an antimalarial ...

SEATTLE, WA / ACCESSWIRE / January 13, 2025 / 1606 Corp. (OTC Pink:CBDW) is excited to express its strong support for strategic investment target Adnexus Biotechnologies Inc. following the company's ...

Hastings, I. M. The origins of antimalarial drug resistance. Trends in Parasitology 20, 512 -518 (2004). Laxminarayan, R. Act now or later? Economics of malaria resistance. American Journal of ...

The drug was also shown to be effective in mouse ... “Astemizole is promising as an antimalarial, but still needs to be evaluated for effectiveness as an antimalarial in humans.” ...

The findings, published in Science, could help scientists use machine learning to predict antimalarial drug resistance and more effectively prioritize the most promising experimental treatments ...